Position in BMY
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$1,985,642
+$1,477,456 QoQ
Shares Held
34,461
+311.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.87%
of 13F equity value
Holder Rank
#840
of 2,506 holders
Holding Since
Mar 2024
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FCG Investment Co holds $10,776,926 across 7 Drug Manufacturers - General names. BMY ranks #3 (18.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,688 | $3,224,068 | |
| 2 | JNJ |
Johnson & Johnson
|
8,748 | $2,221,729 | |
| 3 | BMY |
Bristol Myers Squibb Co
This page
|
34,461 | $1,985,642 | |
| 4 | MRK |
Merck & Co., Inc.
|
12,049 | $1,548,296 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
6,223 | $786,213 | |
| 6 | ABBV |
AbbVie Inc.
|
2,515 | $632,874 | |
| 7 | PFE |
Pfizer Inc
|
15,702 | $378,104 |
All Filings in BMY
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,985,642 | 34,461 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $508,186 | 8,379 | Shares | Sole | 2026-04-09 | |
| 2025-09-30 | $608,534 | 13,493 | Shares | Sole | 2025-10-08 | |
| 2025-06-30 | $463,918 | 10,022 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $643,566 | 10,552 | Shares | Sole | 2025-05-13 | |
| 2024-03-31 | $445,336 | 8,212 | Shares | Sole | 2024-04-19 | |
| No filing history on record for this holder in this stock. | ||||||